Search

Your search keyword '"Heidecke, Harald"' showing total 351 results

Search Constraints

Start Over You searched for: Author "Heidecke, Harald" Remove constraint Author: "Heidecke, Harald"
351 results on '"Heidecke, Harald"'

Search Results

2. Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)

3. Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach

5. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium

9. Integrative Systems Immunology Analysis Reveals Elevated Anti-AGTR1 Levels with Accumulating COVID-19 Symptoms

12. Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS).

14. Allergic manifestations in women with silicone breast implants

16. Protease-Activated Receptor-1 IgG Autoantibodies in Patients with COVID-19

17. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk

18. Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signaling

19. Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood Markers

21. Chronic Fatigue and Dis-Autonomy following COVID-19 Vaccination is Distinguished from Normal Vaccination Response by Altered Blood Markers

25. Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors

27. Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis

29. Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA Antibodies in Heart Transplant Recipients: A Pilot Study

31. Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity

34. Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non‐ischaemic heart failure

35. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

36. Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndrome

37. SARS-CoV-2 infection induces the production of autoantibodies in severe COVID-19 patients in an age-dependent manner

38. Low concentrations of C5a complement receptor antibodies are linked to disease activity and relapse in ANCA ‐associated vasculitis

39. sj-pdf-2-jso-10.1177_23971983231168193 – Supplemental material for Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors

40. sj-pdf-1-jso-10.1177_23971983231168193 – Supplemental material for Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors

41. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19

42. Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19

43. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity

44. Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis.

45. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis

46. Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension

48. Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching

50. Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation

Catalog

Books, media, physical & digital resources